S. regulatory authority, has approved the use of CP for compassionate use in the treatment of patients with a critical COVID-19 infection. NaB inhibitor Below are the general indications for drawing up clinical protocols for the integral management of “COVID-19-convalescent plasma” for which the validation and approval of the Ethics Committees is…[Read more]